Ara
Toplam kayıt 2, listelenen: 1-2
Early shift from ranibizumab to aflibercept for resistant pigment epitelial detachment in classical choroidal neovascularization
(International Journal of Ophthalmology (c/o Editorial Office), 2017)
AIM: To evaluate the therapeutic effect of aflibercept in patients with suboptimal response to ranibizumab therapy in the early period. METHOD: Thirty-eight patients with wet type age related macular degeneration(W-AMD) ...
Reply to the comments by Anforth and Fernandez-Penas
(Medical Journals/Acta D-V, 2017)
[No abstract available]